Biodesix, Inc. (BDSX) vs BioAge Labs Inc. (BIOA)
A side-by-side comparison of Biodesix, Inc. and BioAge Labs Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDSX
Biodesix, Inc.
$28.25HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
BIOA
BioAge Labs Inc.
$6.23HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
Total return — BDSX vs BIOA
growth of $100 · dividends reinvested · last 2yBDSX -14.5% (-7.5%/yr)BIOA -65.3% (-41.1%/yr)BDSX compounded faster over this window
BDSX BIOA
BDSX vs BIOA: by the numbers
- •BIOA is the larger company ($235M vs $230M market cap).
- •Both run net losses; BDSX's is the smaller (-26.97% vs -912.25% net margin).
Metrics side by side
Valuation
| Metric | BDSX | BIOA |
|---|---|---|
| P/S ratio | 2.23 | 22.65 |
| P/B ratio | 25.15 | 0.63 |
Profitability
| Metric | BDSX | BIOA |
|---|---|---|
| Gross margin | 82.50% | 99.39% |
| Operating margin | -31.37% | -1026.28% |
| Net margin | -26.97% | -912.25% |
| ROE | -303.61% | -25.20% |
| ROIC | -25.73% | -28.14% |
Growth (annualized)
| Metric | BDSX | BIOA |
|---|---|---|
| Revenue CAGR (5Y) | 5.99% | N/A |
| Total return CAGR (5Y) | -28.49% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.